Literature DB >> 1415572

Renal hemodynamic actions of lipoxins in rats: a comparative physiological study.

T Katoh1, K Takahashi, D K DeBoer, C N Serhan, K F Badr.   

Abstract

Interactions between either the arachidonate 5-lipoxygenase (5-LO) and 15-LO or 5-LO and 12-LO can lead to the formation of lipoxins. Although the functional significance of lipoxygenase products of arachidonic acid has been recognized increasingly in glomerular inflammation, less is known regarding the specific effects of lipoxins on renal hemodynamics. Here, we examine the renal actions of lipoxin (LX) A4, LXB4, and, the recently identified 7-cis-11-trans-LXA4, which were administered into the renal artery of the euvolemic male Munich-Wistar rat. LXA4 caused increases in renal plasma flow (RPF) and glomerular filtration rate (GFR) in a dose-dependent manner. These effects were reversed during cyclooxygenase inhibition. LXB4 decreased both RPF and GFR, and its mode of action was independent of cyclooxygenase activity. 7-cis-11-trans-LXA4 decreased RPF and GFR, which effects were abolished during systemic infusion of the leukotriene D4 receptor antagonist SKF 104353. Results indicate that each of these lipoxins displays distinct hemodynamic effects via a specific mode of action on the renal vasculature of rats. Moreover, they suggest mechanisms whereby lipoxins may participate in the changes of renal hemodynamics that occur during glomerular inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415572     DOI: 10.1152/ajprenal.1992.263.3.F436

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 2.  Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.

Authors:  C N Serhan; N Chiang
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 3.  Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

Authors:  John D Imig; Md Abdul Hye Khan
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.

Authors:  C B Clish; J A O'Brien; K Gronert; G L Stahl; N A Petasis; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 5.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

6.  Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.

Authors:  S P Colgan; C N Serhan; C A Parkos; C Delp-Archer; J L Madara
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  A novel rat lipoxin A4 receptor that is conserved in structure and function.

Authors:  Nan Chiang; Tomoko Takano; Makoto Arita; Shiro Watanabe; Charles N Serhan
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

8.  Lipoxin synthase activity of human platelet 12-lipoxygenase.

Authors:  M Romano; X S Chen; Y Takahashi; S Yamamoto; C D Funk; C N Serhan
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.

Authors:  Emaad M Abdel-Rahman; Peter M Abadir; Helmy M Siragy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-17       Impact factor: 3.619

Review 10.  Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.

Authors:  Matthieu Legrand; Egbert G Mik; Tanja Johannes; Didier Payen; Can Ince
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.